- Trials with a EudraCT protocol (47)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
47 result(s) found for: Interphalangeal joint.
Displaying page 1 of 3.
EudraCT Number: 2006-000925-71 | Sponsor Protocol Number: HUM 05-032 | Start Date*: 2006-04-27 |
Sponsor Name:University Hospital Ghent | ||
Full Title: TNF-blockade for the treatment of erosive osteoarthritis (OA) of interphalangeal finger joints. Randomized, double blind, placebo-controlled study to evaluate the efficacy of adalimumab 40 mg sc ev... | ||
Medical condition: Erosive interphalangeal osteoarthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003223-53 | Sponsor Protocol Number: AGO/2015/008 | Start Date*: 2015-12-01 |
Sponsor Name:Ghent University Hospital | ||
Full Title: RANKL-blockade for the treatment of erosive osteoarthritis (OA) of interphalangeal finger joints Randomized, double blind, placebo-controlled study to evaluate the efficacy of denosumab 60mg sc ... | ||
Medical condition: erosive osteoarthritis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-003994-18 | Sponsor Protocol Number: EHOA | Start Date*: 2008-02-18 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: EHOA: Etanercept as treatment for Hand OsteoArthritis A randomized, double-blind, placebo-controlled trial to evaluate the clinical efficacy and the structure modifying properties of etanercept 50... | |||||||||||||
Medical condition: Patients with erosive inflammatory osteoarthritis of the interphalangeal joints | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) BE (Completed) AT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001465-20 | Sponsor Protocol Number: FMLD-ARSIDOS-48 | Start Date*: 2022-02-11 | |||||||||||
Sponsor Name:Laboratorios Farmalíder S.A. | |||||||||||||
Full Title: A double-blind, multicenter, randomized clinical trial to assess the efficacy and safety of Montelukast in patients with erosive / inflammatory arthrosis of the hands | |||||||||||||
Medical condition: Erosive / inflammatory arthrosis of the hands | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Temporarily Halted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019110-24 | Sponsor Protocol Number: CZOL446HDE43T | Start Date*: 2010-12-27 | |||||||||||
Sponsor Name:Universitätsklinikum Erlangen | |||||||||||||
Full Title: A PHASE 2, SINGLE-CENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF ZOLEDRONATE IN SUBJECTS WITH EROSIVE HAND OSTEOARTHRITIS | |||||||||||||
Medical condition: Erosive hand osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000712-15 | Sponsor Protocol Number: 001 | Start Date*: 2018-12-17 |
Sponsor Name:Andrew Lindford | ||
Full Title: Prospective Randomised Non-inferiority Nordic Frostbite Treatment Study comparing tPA and iloprost therapy | ||
Medical condition: frostbite; severe frostbite results in devastating injuries leading to significant morbidity from frequent distal extremity amputations | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003425-15 | Sponsor Protocol Number: 2017 | Start Date*: 2017-11-10 | |||||||||||
Sponsor Name:Videncenter for Reumatologi og Rygsygdomme, Rigshospitalet | |||||||||||||
Full Title: Patients with rheumatoid arthritis and synovitis treated with ultrasound guided intraarticular or intramuscular glucocorticoid injection - A randomised, double-blind, controlled study (Panguian) | |||||||||||||
Medical condition: Treatment of synovitis among rheumatoid arthritis patients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001096-31 | Sponsor Protocol Number: M14-171 | Start Date*: 2015-02-19 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Phase 2a, multicenter, randomized, double-blind, placebo-controlled study comparing the safety and efficacy of ABT-981 to placebo in subjects with erosive hand osteoarthritis | |||||||||||||
Medical condition: Adult male and female patients with erosive hand osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) BE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005442-39 | Sponsor Protocol Number: Better Life in Osteoarthritis | Start Date*: 2006-10-24 |
Sponsor Name:Division of Rheumatology | ||
Full Title: Randomized controlled trial of prednisolone in the treatment of osteaoarthritis of the hand | ||
Medical condition: Osteoarthritis of the hands | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000687-33 | Sponsor Protocol Number: HOPE | Start Date*: 2015-11-18 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Randomized placebo-controlled trial to investigate clinical efficacy, anti-inflammatory properties and safety of prednisolone in hand osteoarthritis: a proof-of-concept study | ||
Medical condition: Hand osteoarthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-003906-28 | Sponsor Protocol Number: RC31/17/0447 | Start Date*: 2020-02-24 |
Sponsor Name:CHU de Toulouse | ||
Full Title: Subcutaneous injections of autologous cultured adipose-derived stroma/stem cells to heal refractory ischemic digital ulcers in patients with scleroderma : a phase II study | ||
Medical condition: Patients with systemic sclerosis presenting digital ulcer : - located beyond the proximal interphalangeal joint, on finger surface (included periungueal ulcers), - of ischemic origin according to... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000844-17 | Sponsor Protocol Number: PsA 1.1 | Start Date*: 2006-05-29 |
Sponsor Name:Vienna Medical University | ||
Full Title: A multi-centre randomized placebo-controlled double blind study of Rituximab in patients with active PsA | ||
Medical condition: Psoriatic Arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) SK (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002611-96 | Sponsor Protocol Number: ANAK/IL-01 | Start Date*: 2014-02-12 |
Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut MAR) | ||
Full Title: Pilot study to determine the efficacy of anakinra (antagonist of interleukin-1 receptor) administered for 3 months in improving inflammatory signs observed by MRI in patients with erosive/inflammat... | ||
Medical condition: Patients with erosive/inflammatory hand osteoarthritis. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001944-36 | Sponsor Protocol Number: 20170149 | Start Date*: 2018-05-21 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Phase 1b/2a Study to Evaluate the Safety and Efficacy of AMG 592 in Subjects with Active Rheumatoid Arthritis With Inadequate Response to Standard of Care Therapy | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) PL (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012703-25 | Sponsor Protocol Number: PHSU02 | Start Date*: 2009-11-03 | |||||||||||
Sponsor Name:Pergamum AB | |||||||||||||
Full Title: A prospective double-blind, randomised concept study of PXL01 versus placebo in flexor tendon surgery. | |||||||||||||
Medical condition: Patients with flexor tendon injuries in zone I or II that are admitted to the respective site will be considered for inclusion and informed about the study. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DK (Completed) DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005285-38 | Sponsor Protocol Number: IM101-591 | Start Date*: 2020-01-14 | |||||||||||
Sponsor Name:The University of Leeds | |||||||||||||
Full Title: Phase II proof of concept study of Abatacept (Orencia) in individuals who aRe Considered At risk of Developing Inflammatory Arthritis | |||||||||||||
Medical condition: Inflammatory arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005365-61 | Sponsor Protocol Number: ACCOST | Start Date*: 2010-01-20 | |||||||||||
Sponsor Name:Med. Fakultaet der Friedrich-Alexander Universitaet Erlangen-Nuernberg | |||||||||||||
Full Title: A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH EROSIVE HAND OSTEOARTHRITIS | |||||||||||||
Medical condition: Erosive osteoarthritis of the hand (EHOA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004779-36 | Sponsor Protocol Number: BMTI-2006-03-EU | Start Date*: 2007-01-22 | |||||||||||
Sponsor Name:BioMimetic Therapeutic Inc | |||||||||||||
Full Title: A Human Clinical Trial to Evaluate the Safety and Clinical Utility of GEM OS1 as a Bone Regeneration System in Foot and Ankle Arthrodesis Procedures | |||||||||||||
Medical condition: For use as a bone void filler for voids or gaps that are not intrinsic to the stability of bony structure. Treatment of surgically created osseous defects or osseous defects resulting from patholo... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FR (Completed) AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004641-33 | Sponsor Protocol Number: DIA2020-01 | Start Date*: 2021-02-16 | |||||||||||||||||||||
Sponsor Name:Diakonhjemmet Hospital | |||||||||||||||||||||||
Full Title: The Methotrexate in ERosive INflammatory Osteoarthritis (MERINO) trial | |||||||||||||||||||||||
Medical condition: Norwegian adult males and females with symptomatic erosive inflammatory hand osteoarthritis. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NO (Trial now transitioned) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004359-32 | Sponsor Protocol Number: 230LE201 | Start Date*: 2017-02-01 | |||||||||||
Sponsor Name:Biogen Idec Research Limited | |||||||||||||
Full Title: A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects with Systemic Lupus Erythematosus and Active Skin Manifestations and in... | |||||||||||||
Medical condition: Systemic Lupus Erythematosus (SLE) with Active Skin Manifestations and Active Cutaneous Lupus Erythematosus (CLE) with or without Systemic Manifestations | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
